Argent BioPharma Limited (LON:MXC – Get Free Report)’s share price shot up 4.8% on Tuesday . The company traded as high as GBX 22 ($0.28) and last traded at GBX 22 ($0.28). 264 shares were traded during mid-day trading, a decline of 99% from the average session volume of 26,353 shares. The stock had previously closed at GBX 21 ($0.27).
Argent BioPharma Trading Up 4.8 %
The firm’s 50 day simple moving average is GBX 22 and its 200-day simple moving average is GBX 21.73. The stock has a market capitalization of £9.65 million, a price-to-earnings ratio of -13.25 and a beta of 1.03.
About Argent BioPharma
MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia.
Further Reading
- Five stocks we like better than Argent BioPharma
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- How to Evaluate a Stock Before Buying
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- 3 Warren Buffett Stocks to Buy Now
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Argent BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argent BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
